Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8982 |
High Similarity |
NPD6959 |
Discontinued |
0.8953 |
High Similarity |
NPD6559 |
Discontinued |
0.8927 |
High Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8916 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8851 |
High Similarity |
NPD8313 |
Approved |
0.8851 |
High Similarity |
NPD8312 |
Approved |
0.8779 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8728 |
High Similarity |
NPD7074 |
Phase 3 |
0.8671 |
High Similarity |
NPD7054 |
Approved |
0.8621 |
High Similarity |
NPD7472 |
Approved |
0.8617 |
High Similarity |
NPD8151 |
Discontinued |
0.8613 |
High Similarity |
NPD3818 |
Discontinued |
0.8596 |
High Similarity |
NPD6232 |
Discontinued |
0.8587 |
High Similarity |
NPD6776 |
Approved |
0.8587 |
High Similarity |
NPD6777 |
Approved |
0.8587 |
High Similarity |
NPD6779 |
Approved |
0.8587 |
High Similarity |
NPD6778 |
Approved |
0.8587 |
High Similarity |
NPD6780 |
Approved |
0.8587 |
High Similarity |
NPD6782 |
Approved |
0.8587 |
High Similarity |
NPD6781 |
Approved |
0.8571 |
High Similarity |
NPD6797 |
Phase 2 |
0.8563 |
High Similarity |
NPD5844 |
Phase 1 |
0.8555 |
High Similarity |
NPD7473 |
Discontinued |
0.8554 |
High Similarity |
NPD4380 |
Phase 2 |
0.8523 |
High Similarity |
NPD7251 |
Discontinued |
0.8497 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8497 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8497 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8475 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8449 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.8404 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.8404 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.8402 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8402 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8398 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8391 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8371 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8363 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8353 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8351 |
Intermediate Similarity |
NPD7698 |
Approved |
0.8351 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.8351 |
Intermediate Similarity |
NPD7697 |
Approved |
0.8315 |
Intermediate Similarity |
NPD6535 |
Approved |
0.8315 |
Intermediate Similarity |
NPD6534 |
Approved |
0.8304 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8295 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.8284 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8272 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.8238 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.8238 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.8235 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8201 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.8187 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8187 |
Intermediate Similarity |
NPD7874 |
Approved |
0.8187 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.8182 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.8182 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.8171 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.8156 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8144 |
Intermediate Similarity |
NPD7801 |
Approved |
0.8144 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8129 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8092 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8084 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.8081 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.8065 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.8065 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.8065 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.8059 |
Intermediate Similarity |
NPD3226 |
Approved |
0.8057 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8046 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8036 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8021 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.8021 |
Intermediate Similarity |
NPD8319 |
Approved |
0.8 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7989 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7977 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7939 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7939 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7931 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7929 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7929 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7929 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7907 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7886 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7874 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7871 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7849 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7849 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7829 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7818 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7816 |
Intermediate Similarity |
NPD37 |
Approved |
0.7809 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7797 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7796 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7784 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7784 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7784 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7771 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7765 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7765 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7733 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7725 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7711 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7704 |
Intermediate Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7692 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7692 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7674 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7665 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7647 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7633 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.763 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7624 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7622 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7616 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7616 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7596 |
Intermediate Similarity |
NPD8058 |
Clinical (unspecified phase) |
0.7596 |
Intermediate Similarity |
NPD8059 |
Phase 3 |
0.7588 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7576 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7574 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.756 |
Intermediate Similarity |
NPD5408 |
Approved |
0.756 |
Intermediate Similarity |
NPD5405 |
Approved |
0.756 |
Intermediate Similarity |
NPD5404 |
Approved |
0.756 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7527 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7514 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7474 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7473 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7473 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7473 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7456 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7456 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7433 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7429 |
Intermediate Similarity |
NPD920 |
Approved |
0.7427 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7427 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7421 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7412 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7405 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7396 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7386 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7377 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.736 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7353 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7349 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7322 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7314 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD8285 |
Discontinued |
0.7308 |
Intermediate Similarity |
NPD919 |
Approved |
0.7294 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7289 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7283 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7277 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7257 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.725 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7241 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7233 |
Intermediate Similarity |
NPD7930 |
Approved |
0.7229 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7228 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7225 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7222 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7211 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7194 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7194 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7165 |
Intermediate Similarity |
NPD4287 |
Approved |
0.716 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD1613 |
Approved |
0.716 |
Intermediate Similarity |
NPD943 |
Approved |
0.7152 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7128 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.711 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7076 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7045 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7043 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7042 |
Intermediate Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.7028 |
Intermediate Similarity |
NPD8366 |
Approved |
0.7018 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7018 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7011 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.701 |
Intermediate Similarity |
NPD7999 |
Approved |
0.7006 |
Intermediate Similarity |
NPD2798 |
Approved |
0.6995 |
Remote Similarity |
NPD5761 |
Phase 2 |
0.6995 |
Remote Similarity |
NPD5760 |
Phase 2 |
0.6994 |
Remote Similarity |
NPD651 |
Clinical (unspecified phase) |
0.6978 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6954 |
Remote Similarity |
NPD2438 |
Suspended |
0.6941 |
Remote Similarity |
NPD3764 |
Approved |
0.6941
|
Remote Similarity |
NPD6798 |
Discontinued |